Table of Content

1 Market Overview of Female Infertility Drugs
1.1 Female Infertility Drugs Market Overview
1.1.1 Female Infertility Drugs Product Scope
1.1.2 Female Infertility Drugs Market Status and Outlook
1.2 Global Female Infertility Drugs Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Female Infertility Drugs Market Size by Region (2024-2034)
1.4 Global Female Infertility Drugs Historic Market Size by Region (2024-2024)
1.5 Global Female Infertility Drugs Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Female Infertility Drugs Market Size (2024-2034)
1.6.1 North America Female Infertility Drugs Market Size (2024-2034)
1.6.2 Europe Female Infertility Drugs Market Size (2024-2034)
1.6.3 Asia-Pacific Female Infertility Drugs Market Size (2024-2034)
1.6.4 Latin America Female Infertility Drugs Market Size (2024-2034)
1.6.5 Middle East & Africa Female Infertility Drugs Market Size (2024-2034)
2 Female Infertility Drugs Market by Type
2.1 Introduction
2.1.1 Parenteral
2.1.2 Oral
2.1.3 Others
2.2 Global Female Infertility Drugs Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Female Infertility Drugs Historic Market Size by Type (2024-2024)
2.2.2 Global Female Infertility Drugs Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Female Infertility Drugs Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Female Infertility Drugs Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Female Infertility Drugs Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Female Infertility Drugs Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Female Infertility Drugs Revenue Breakdown by Type (2024-2034)
3 Female Infertility Drugs Market Overview by Application
3.1 Introduction
3.1.1 Ovarian Hyperstimulation Syndrome
3.1.2 Multiple-gestation Pregnancies
3.1.3 Multiple-birth Infants
3.1.4 Premature Labor
3.1.5 Low Birth Weight
3.1.6 Risk of Cesarean Delivery
3.2 Global Female Infertility Drugs Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Female Infertility Drugs Historic Market Size by Application (2024-2024)
3.2.2 Global Female Infertility Drugs Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Female Infertility Drugs Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Female Infertility Drugs Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Female Infertility Drugs Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Female Infertility Drugs Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Female Infertility Drugs Revenue Breakdown by Application (2024-2034)
4 Female Infertility Drugs Competition Analysis by Players
4.1 Global Female Infertility Drugs Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Infertility Drugs as of 2022)
4.3 Date of Key Players Enter into Female Infertility Drugs Market
4.4 Global Top Players Female Infertility Drugs Headquarters and Area Served
4.5 Key Players Female Infertility Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Female Infertility Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Allergan Plc
5.1.1 Allergan Plc Profile
5.1.2 Allergan Plc Main Business
5.1.3 Allergan Plc Female Infertility Drugs Products, Services and Solutions
5.1.4 Allergan Plc Female Infertility Drugs Revenue (US$ Million) & (2024-2024)
5.1.5 Allergan Plc Recent Developments
5.2 Ferring BV
5.2.1 Ferring BV Profile
5.2.2 Ferring BV Main Business
5.2.3 Ferring BV Female Infertility Drugs Products, Services and Solutions
5.2.4 Ferring BV Female Infertility Drugs Revenue (US$ Million) & (2024-2024)
5.2.5 Ferring BV Recent Developments
5.3 Merck KGaA
5.3.1 Merck KGaA Profile
5.3.2 Merck KGaA Main Business
5.3.3 Merck KGaA Female Infertility Drugs Products, Services and Solutions
5.3.4 Merck KGaA Female Infertility Drugs Revenue (US$ Million) & (2024-2024)
5.3.5 Novartis AG Recent Developments
5.4 Novartis AG
5.4.1 Novartis AG Profile
5.4.2 Novartis AG Main Business
5.4.3 Novartis AG Female Infertility Drugs Products, Services and Solutions
5.4.4 Novartis AG Female Infertility Drugs Revenue (US$ Million) & (2024-2024)
5.4.5 Novartis AG Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Female Infertility Drugs Products, Services and Solutions
5.5.4 Sanofi Female Infertility Drugs Revenue (US$ Million) & (2024-2024)
5.5.5 Sanofi Recent Developments
6 North America
6.1 North America Female Infertility Drugs Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Female Infertility Drugs Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Female Infertility Drugs Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Female Infertility Drugs Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Female Infertility Drugs Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Female Infertility Drugs Market Dynamics
11.1 Female Infertility Drugs Industry Trends
11.2 Female Infertility Drugs Market Drivers
11.3 Female Infertility Drugs Market Challenges
11.4 Female Infertility Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Female Infertility Drugs Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Female Infertility Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Female Infertility Drugs Market Size Share by Region (2024-2024)
Table 4. Global Female Infertility Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Female Infertility Drugs Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Female Infertility Drugs Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Female Infertility Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Female Infertility Drugs Revenue Market Share by Type (2024-2024)
Table 9. Global Female Infertility Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Female Infertility Drugs Revenue Market Share by Type (2024-2034)
Table 11. North America Female Infertility Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Female Infertility Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Female Infertility Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Female Infertility Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Female Infertility Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Female Infertility Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Female Infertility Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Female Infertility Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Female Infertility Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Female Infertility Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Female Infertility Drugs Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Female Infertility Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Female Infertility Drugs Revenue Market Share by Application (2024-2024)
Table 24. Global Female Infertility Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Female Infertility Drugs Revenue Market Share by Application (2024-2034)
Table 26. North America Female Infertility Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Female Infertility Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Female Infertility Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Female Infertility Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Female Infertility Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Female Infertility Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Female Infertility Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Female Infertility Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Female Infertility Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Female Infertility Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Female Infertility Drugs Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Female Infertility Drugs Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Infertility Drugs as of 2022)
Table 39. Date of Key Players Enter into Female Infertility Drugs Market
Table 40. Global Female Infertility Drugs Key Players Headquarters and Area Served
Table 41. Female Infertility Drugs Product Solution and Service
Table 42. Global Female Infertility Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Allergan Plc Basic Information List
Table 45. Allergan Plc Description and Business Overview
Table 46. Allergan Plc Female Infertility Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Female Infertility Drugs Business of Allergan Plc (2024-2024)
Table 48. Allergan Plc Recent Developments
Table 49. Ferring BV Basic Information List
Table 50. Ferring BV Description and Business Overview
Table 51. Ferring BV Female Infertility Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Female Infertility Drugs Business of Ferring BV (2024-2024)
Table 53. Ferring BV Recent Developments
Table 54. Merck KGaA Basic Information List
Table 55. Merck KGaA Description and Business Overview
Table 56. Merck KGaA Female Infertility Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Female Infertility Drugs Business of Merck KGaA (2024-2024)
Table 58. Merck KGaA Recent Developments
Table 59. Novartis AG Basic Information List
Table 60. Novartis AG Description and Business Overview
Table 61. Novartis AG Female Infertility Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Female Infertility Drugs Business of Novartis AG (2024-2024)
Table 63. Novartis AG Recent Developments
Table 64. Sanofi Basic Information List
Table 65. Sanofi Description and Business Overview
Table 66. Sanofi Female Infertility Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Female Infertility Drugs Business of Sanofi (2024-2024)
Table 68. Sanofi Recent Developments
Table 69. North America Female Infertility Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 70. North America Female Infertility Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 71. Europe Female Infertility Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 72. Europe Female Infertility Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 73. Asia-Pacific Female Infertility Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 74. Asia-Pacific Female Infertility Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 75. Asia-Pacific Female Infertility Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 76. Asia-Pacific Female Infertility Drugs Market Share by Region (2024-2024)
Table 77. Asia-Pacific Female Infertility Drugs Market Share by Region (2024-2034)
Table 78. Latin America Female Infertility Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 79. Latin America Female Infertility Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 80. Latin America Female Infertility Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 81. Middle East & Africa Female Infertility Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 82. Middle East & Africa Female Infertility Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 83. Middle East & Africa Female Infertility Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 84. Female Infertility Drugs Market Trends
Table 85. Female Infertility Drugs Market Drivers
Table 86. Female Infertility Drugs Market Challenges
Table 87. Female Infertility Drugs Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Infertility Drugs Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Female Infertility Drugs Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Female Infertility Drugs Market Share by Regions: 2022 VS 2034
Figure 4. Global Female Infertility Drugs Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Female Infertility Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Female Infertility Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Female Infertility Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Female Infertility Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Female Infertility Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Parenteral
Figure 11. Global Parenteral Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Oral
Figure 13. Global Oral Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Female Infertility Drugs Market Size Share by Type: 2022 & 2034
Figure 17. North America Female Infertility Drugs Revenue Market Share by Type (2024-2034)
Figure 18. Europe Female Infertility Drugs Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Female Infertility Drugs Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Female Infertility Drugs Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Female Infertility Drugs Revenue Market Share by Type (2024-2034)
Figure 22. Ovarian Hyperstimulation Syndrome Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Multiple-gestation Pregnancies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Multiple-birth Infants Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Premature Labor Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Low Birth Weight Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Risk of Cesarean Delivery Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Global Female Infertility Drugs Market Size Share by Application: 2022 & 2034
Figure 29. North America Female Infertility Drugs Revenue Market Share by Application (2024-2034)
Figure 30. Europe Female Infertility Drugs Revenue Market Share by Application (2024-2034)
Figure 31. Asia-Pacific Female Infertility Drugs Revenue Market Share by Application (2024-2034)
Figure 32. Latin America Female Infertility Drugs Revenue Market Share by Application (2024-2034)
Figure 33. Middle East and Africa Female Infertility Drugs Revenue Market Share by Application (2024-2034)
Figure 34. Female Infertility Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 35. Global Top 5 and Top 10 Players Female Infertility Drugs Market Share in 2022
Figure 36. North America Female Infertility Drugs Market Share by Country (2024-2034)
Figure 37. U.S. Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 38. Canada Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 39. Germany Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 40. France Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 41. U.K. Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 42. Italy Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 43. Russia Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 44. Nordic Countries Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 45. Asia-Pacific Female Infertility Drugs Market Share by Region (2024-2034)
Figure 46. China Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 47. Japan Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 48. South Korea Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 49. Southeast Asia Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 50. India Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 51. Australia Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 52. Latin America Female Infertility Drugs Market Share by Country (2024-2034)
Figure 53. Mexico Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 54. Brazil Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 55. Middle East & Africa Female Infertility Drugs Market Share by Country (2024-2034)
Figure 56. Turkey Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 57. Saudi Arabia Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 58. UAE Female Infertility Drugs Market Size (2024-2034) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report